ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

QNRX Quoin Pharmaceuticals Ltd

0.686
-0.034 (-4.72%)
2024年6月15日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Quoin Pharmaceuticals Ltd QNRX NASDAQ Depository Receipt
  前日比 前日比 % 現在値 時刻
-0.034 -4.72% 0.686 08:53:04
始値 安値 高値 終値 前日終値
0.72 0.68155 0.7382 0.6862 0.72
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/1221:00GLOBEQuoin Pharmaceuticals Announces Signing of Research..
2024/5/1105:10EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/5/0921:30GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
2024/5/0905:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/5/0305:10GLOBEQuoin Pharmaceuticals to Announce First Quarter 2024..
2024/3/1405:05GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
2024/3/1320:03IHMARKETNEWSMixed Futures Amidst Quiet Economic Schedule; Oil Prices..
2024/3/0906:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/3/0906:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/3/0906:01EDGAR2Form 8-K - Current report
2024/3/0806:05GLOBEQuoin Pharmaceuticals Announces Fourth Quarter and 2023..
2024/3/0707:07EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
2024/3/0706:01EDGAR2Form 8-K - Current report
2024/3/0522:00GLOBEQuoin Pharmaceuticals Announces Pricing of $6.5 Million..
2024/3/0507:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/3/0422:00GLOBEQuoin Pharmaceuticals Announces FDA Clearance to Recruit..
2024/2/2720:01EDGAR2Form DEF 14A - Other definitive proxy statements
2024/2/1514:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/2/1410:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1406:50EDGAR2Form S-1/A - General form for registration of securities..
2024/2/1406:30EDGAR2Form PRE 14A - Other preliminary proxy statements
2024/2/1307:12EDGAR2Form S-1 - General form for registration of securities under..
2024/2/0822:00GLOBEQuoin Pharmaceuticals Files U.S. and International Patent..
2024/1/3106:05EDGAR2Form 8-K - Current report
2023/12/1907:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/12/1907:29EDGAR2Form 8-K - Current report
2023/12/1322:30GLOBEQuoin Pharmaceuticals Announces FDA Clearance of Clinical..
2023/11/1007:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/11/1007:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1007:10EDGAR2Form 8-K - Current report
2023/11/0907:46GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
2023/11/0807:14EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/11/0706:17EDGAR2Form 8-K - Current report
2023/11/0321:41GLOBEQuoin Pharmaceuticals Announces Third Quarter 2023 Financial..
2023/11/0206:18EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/11/0205:59EDGAR2Form 8-K - Current report
2023/10/3105:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/3105:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/3105:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/3105:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/3105:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2422:32GLOBEREPEAT -- Quoin Pharmaceuticals Announces Additional..
2023/10/2421:28GLOBEQuoin Pharmaceuticals Announces Additional Positive Clinical..
2023/10/2006:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/9/1505:38EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/9/1219:03EDGAR2Form DEF 14A - Other definitive proxy statements
2023/9/0202:38EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/8/0405:51EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/0403:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0306:01EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock